Galaxy Therapeutics Completes Enrollment in Pivotal SEAL IT IDE Trial
PR Newswire —
MILPITAS, Calif., Dec. 23, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced it has successfully completed enrollment in SEAL IT, its U.S. IDE trial evaluating the SEAL device for brain...